TheraPure DNA phosphoramidites were engineered specifically for oligonucleotide manufacturers requiring tightly controlled impurity profiles, strictly controlled processes with thorough documentation, and a rigorous process change control. With our in-house high-definition, advanced analytical capabilities including LC-MS, GC, HPLC, 31P NMR and 1H NMR, DNA and RNA phosphoramidites are ideal for meeting possible regulatory requirements. However, collaborative, customized specifications are always welcome for further discussion.
For more than 30 years, our OEM and custom custom capabilities in research, development, and manufacturing of nucleic acids continue to be key resources for our global partners at molecular diagnostic, pharmaceutical, and life science research companies.
TheraPure DNA Phosphoramidite highlights
- Raw materials and intermediates are always QC tested using analytical technologies (listed above)
- State-of-the-art purification methods utilized to obtain the highest amidite purity
- Overall, high purity and tight critical impurity level control yields excellent batch-to-batch reproducibility
Click images to enlarge
dA(Bz) CEP
dC(Bz) CEP
dG(iBu) CEP
dT CEP
| dA(Bz) CEP | dC(Bz) CEP | dG(iBu) CEP | dT CEP | |
|---|---|---|---|---|
| Cat. No. | 27-2030 | 27-2032 | 27-2034 | 27-2036 |
| Formula | C47H52N7O7P | C46H52N5O8P | C44H54N7O8P | C40H49N4O8P |
| Molecular weight | 857.95 g/mol | 833.93 g/mol | 839.92 g/mol | 744.82 g/mol |
| CAS # | 98796-53-3 | 102212-98-6 | 93183-15-4 | 98796-51-1 |
| HPLC purity* | ≥ 99% |
|||
| 31P NMR purity* | ≥ 99% |
|||
| Solution Clarity | Free from undissolved particulate at 0.2M solution in ACN | |||
| Appearance | White to pale yellow powder | |||
| Residual Solvent | ≤ 3.0% total % by weight | |||
| Shipping/Storage condition | Ambient / –20 °C | |||
| Water content | ≤ 0.3% | |||
| Material Origin | Non-animal source (no TSE/BSE risk) | |||
* For more specification details, contact us.
Order now
Traditional base protection methods are used to ensure quality and reliability for routine oligonucleotide synthesis.
Click images to enlarge
dA(Bz) CEP
dC(Bz) CEP
dG(iBu) CEP
dT CEP
| dA(Bz) CEP | dC(Bz) CEP | dG(iBu) CEP | dT CEP | |
|---|---|---|---|---|
| Cat. No. | 27-1730 | 27-1732 | 27-1734 | 27-1736 |
| Formula | C47H52N7O7P | C46H52N5O8P | C44H54N7O8P | C40H49N4O8P |
| Molecular weight | 857.95 g/mol | 833.93 g/mol | 839.92 g/mol | 744.82 g/mol |
| CAS # | 98796-53-3 | 102212-98-6 | 93183-15-4 | 98796-51-1 |
| HPLC purity | ≥ 98.0% | |||
| 31P NMR purity | ≥ 98.0% | |||
| Water content (KF Method) | ≤ 0.3% | |||
| Shipping / Storage condition | Ambient / –20 °C | |||
| Solution Clarity | Free from undissolved particulate at 0.2M solution in ACN | |||
| Material Origin | Non-animal source (no TSE/BSE risk) | |||
Order now
Fast Deprotect DMF-dG, iPrPAC-dG, PAC-dA, Ac-dC, and iBu-dC phosphoramidites are ideal for applications requiring mild deprotection to preserve the integrity of oligonucleotides containing sensitive dyes, labels, or other modifications, which may be unstable with prolonged exposure to strong alkaline conditions. Fast Deprotect phosphoramidites permit the removal of base protecting groups under mild or accelerated conditions without the need for special reagents.
Click images to enlarge
iPrPAC-dG CEP
PAC-dA CEP
Ac-dC CEP
DMF-dG CEP
| iPrPAC-dG CEP | PAC-dA CEP | Ac-dC CEP | DMF-dG CEP | IBU-dC CEP | |
|---|---|---|---|---|---|
| Cat. No. (TheraPure) | N/A | N/A | 27-2027 | N/A |
N/A |
| Cat. No. (standard) | 27-1726 | 27-1723 | 29-1727 | 27-1737 | 27-1725 |
| Formula | C51H60N7O9P | C48H54N7O8P | C41H50N5O8P | C43H53N8O7P | C43H54N5O8P |
| Molecular weight | 946.05 g/mol | 887.96 g/mol | 771.8 g/mol | 824.9 g/mol | 839.92g/mol |
| CAS # | 150065-82-0 | 110543-74-3 | 154110-40-4 | 330628-04-1 | 110522-84-4 |
| HPLC purity |(TheraPure)* | ≥ 98.0% | ≥ 98.0% | ≥ 98% | (≥ 99%) | ≥ 98.0% | ≥ 98.0% |
| 31P NMR purity | (TheraPure)* | ≥ 98.0% | ≥ 98.0% | ≥ 98% | (≥ 99%) | ≥ 98.0% | ≥ 98.0% |
| Shipping / Storage condition |
Ambient / –20 °C |
||||
| Material Origin | Non-animal source (no TSE/BSE risk) | ||||
Please scroll right to see entire table ›
* For more specification details, contact us.
Order now
Process and supply chain control
- Processes are monitored from material procurement through final QC and product release, providing batch-to-batch reproducibility
- A controlled raw material supply chain and established vendor partnerships ensure consistency and security of supply
- Purity of each DNA phosphoramidite lot is assessed by HPLC and 31P NMR analyses
- Rigorously controlled manufacturing processes minimize levels of reactive P(III) impurities which could be incorporated into the oligonucleotide and result in the accumulation of by-products
Custom services
- Custom manufacturing services are available to assist in the development or scale-up of phosphoramidite compounds
- Specialty phosphoramidites can be manufactured with base or sugar (2′, 3′ or 5′ positions) modifications
Flexible packaging
- Common oligo synthesizer pack sizes are available for immediate delivery
- Custom and bulk packaging are also available. Contact us to learn more.
Not finding what you are looking for? We also offer RNA phosphoramidites, specialty phosphoramidites, dye-labeled phosphoramidites, 2′-modifications, linker and spacer phosphoramidites, and succinates and CPG support synthesis supports. Contact us to learn more.
Other primers, probes, and nucleotides
Technical resources
Support
For Research Use Only. Not for use in diagnostic procedures.
